Research analysts at Zacks Research reduced their Q1 2026 EPS estimates for shares of GSK in a report issued on Wednesday, ...

The Phase IIa study (NCT06235905) met its primary endpoint – showing a clinically meaningful improvement of -6.1 on the ...

The vaccine that’s helped protect millions of people worldwide from the COVID-19 virus and its variants would not have been ...

Last year, demand fueled a 67% surge in the iShares Semiconductor ETF SOXX, led by Nvidia and buoyed by other companies with AI chips such as Advanced Micro Devices Inc. (AMD) and Broadcom Inc. (AVGO) ...

Considering the reasons behind the jump in licensing deal values, Chan added: “Licensing agreement deal values for mRNA-based ...

Exclusive: One in three researchers say their peers force them to carry out tests with animals if their work is to be ...

London-based GSK is crossing the pond to form a new lung disease research collaboration with Boston scientists. | ...

Clinical stage biopharma Kezar Life Sciences is discontinuing its lupus nephritis (LN) clinical programme following the death ...

The global malaria treatment market is projected to be valued at approximately USD 1.8 billion in the fiscal year 2023, an ...

The job sector in the United Kingdom provides numerous chances for international workers, particularly via the UK Work Visa. According to Last Stop Booking, the average monthly income for positions in ...

Bupropion hydrochloride extended-release tablets are widely prescribed for the treatment of major depressive disorder and for ...

Interim phase 3 results showed the IL-13 monoclonal antibody improves histology and symptoms in EoE, even in participants ...